Chemoradiotherapy for uterine cancer: Current status and perspectives

International Journal of Clinical Oncology

Volumn 9, Issue 6, 2004, Pages 458-470

  Kuzuya, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chemoradiotherapy; Chemotherapy; Radiotherapy; Uterine cervical cancer

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; EPIRUBICIN; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; MITOMYCIN; VINCRISTINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UTERUS CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; PROGNOSIS; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 12444290905     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-004-0452-y     Document Type: Review

References (70)

1. Sekiya H. 37th Annual Report of the Uterine Cancer, Gynecologic Oncology Committee (in Japanese) (2003) Acta Obstet Gynecol Jpn 55:743-769
2. Benedet JL, Odicino F, Maisonneuve P, et al. (2001) Carcinoma of the cervix uteri. J Epidemiol Biostat 6:7-43
3. Gadducci A, Cosio S, Cionini L, et al. (2001) Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of advanced cervical cancer. Anticancer Res 21:3525-3534
4. Souhami L, Gil RA, Allan SE, et al. (1991) A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 9:970-977
5. Chauvergne J, Lhomme C, Rohart J, et al. (1993) Neoadjuvant chemotherapy of stage IIb or Iii cancers of the uterine cervix. Long-term results of a multicenter randomized trial of 151 patients. Bull Cancer 80:1069-1079
6. Chiara S, Bruzzone M, Merlini L, et al. (1994) Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group). Am J Clin Oncol 17:294-297
7. Kumar L, Kaushal R, Nandy M, et al. (1994) Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol 54:307-315
8. Tattersall MH, Lorvidhaya V, Vootiprux V, et al. (1995) Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association. J Clin Oncol 13:444-451
9. Sundfor K, Trope CG, Hogberg T, et al. (1996) Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluoruracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 77:2371-2378
10. Leborgne F, Leborgne JH, Doldan R, et al. (1997) Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 37:343-350
11. Symonds RP, Habeshaw T, Reed NS, et al. (2000) The Scottish and Manchester randomized trial of neo- adjuvant chemotherapy for advanced cervical cancer. Eur J Cancer 36:994-1001
12. Tierney JF, Stewart LA, Parmar MKB. (1999) Can the published date tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix? Eur J Cancer 35:406-409
13. Serur E, Mathews RP, Gates J, et al. (1997) Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Gynecol Oncol 65:348-356
14. Chen CA, Cheng WF, Wei LH, et al. (2001) Radical hysterectomy alone or combined with neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma. J Formos Med Assoc 101:195-202
15. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, et al. (2002) Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies. Ann Oncol 13:1212-1219
16. Sardi JE, Giaroli A, Sananes C, et al. (1997) Longterm follow-up of the first randomization trial using neoadjuvant chemotheraqpy in stable Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 67:61-69
17. Chang TC, Lai CH, Hong JH, et al. (2000) Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol 18:1740-1747
18. Benedetti-Panici P, Greggi S, Colombo A, et al. (2002) Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20:179-188
19. Tierney J. (2003) Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systemic review and meta-analysis of individual patient data from 21 randomized trials. Eur J Cancer 39:2470-2486
20. Napolitano C, Imperano F, Mossa B, et al. (2002) The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial. Eur J Gynaecol Oncol. 24:51-59
21. Sardi JE, Sananes CE, Giaroli AA, et al. (1998) Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomized controlled trial. Int J Gynecol Cancer 8:441-450
22. Sardi JE, Sananes CE, Giaroli AA, et al. (1996) Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer 6:85-93
23. Thomas GM. (1999) Improved treatment for cervical cancer. Concurrent chemotherapy and radiotherapy. N Engl J Med 340:1198-1201
24. Stehman FB, Bundy BN, Keys H, et al. (1993) Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol 11:1523-1528
25. Tseng CJ, Chang CT, Lai CH, et al. (1997) A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 66:52-58
26. Colombo A, Landoni F, Cormio G, et al. (1997) Concurrent carboplatin/5FU and radiotherapy compared to radiotherapy alone in locally advanced cervical carcinoma: a case control study. Tumori 83:895-899
27. Thomas G, Dembo A, Ackerman I, et al. (1998) A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 69:137-145
28. Whitney CW, Sause W, Bundy BN, et al. (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339-1348
29. Rose PG, Bundy BN, Watkins EB, et al. (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153
30. Keys HM, Bundy BN, Stehman FB, et al. (1999) Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154-1161
31. Morris M, Eifel PJ, Lu J, et al. (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137-1143
32. Peters WA, Liu PY, Barrett RJ, et al. (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol 18:1606-1613
33. Eifel PJ, Winter K, Morris M, et al. (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group Trial(RTOG)90-01. J Clin Oncol 22: 872-880
34. Rose PG, Bundy BN (2002) Chemoradiation for locally advanced cervical cancer: does it help? J Clin Oncol 20:891-896
35. NCI Clinical Announcement (1999) Concurrent chemoradiation for cervical cancer. United States Department of Public Health, Washington DC
36. Green JA, Kirwan JM, Tierney JF, et al. (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358:781-786
37. Lukka H, Hirte H, Fyles A, et al. (2002) Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - a meta-analysis. Clin Oncol 14:203-212
38. Pearcey RG, Brungage WD, Drouin P, et al. (2000) A clinical trial comparing concurrent cisplatin and radiation therapy versus radiation alone for locally advanced squamous cell carcinoma of the cervix carried out by the National Cancer Institute Canada Clinical Trial Group. Proc Am Soc Clin Oncol 19:1497
39. Pearcey RG, Brungage WD. Drouin P, et al. (2002) Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell carcinoma of the cervix. J Clin Oncol 20:891-893
40. Heller PB, Maletano JH, Bundy BN, et al. (1990) Clinical pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study. Gynecol Oncol 38:425-430
41. Kirwan JM, Symonds P, Green JA, et al. (2003) A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 68:217-226
42. Jurado M, Martines-Monge R, Lopez-Garcia G, et al. (1999) Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol Oncol 74:30-37
43. Mancuso S, Smaniotto D, Panici PB, et al. (2000) Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 78:324-328
44. Toita T, Moromizato H, Ogawa K. et al. (2000) Concurrent chemoradiotherapy for locoregionally advanced uterine cervical cancer (in Japanese). Jpn J Clin Radiol 45:1639-1642
45. Horie M, Saitho T, Sagae S. et al. (2002) Clinical evaluation of chemoradiotherapy for advanced uterine cervical cancer (in Japanese). Sanfujinka no Sekai 54:99-104
46. Tanaka N, Mitsuhashi A, Sekiya S (2003) Concurrent chemoradiation therapy for advanced cervical cancer (in Japanese). Acta Obstet Gyenecol Jpn 55:1163-1169
47. Kamiura S, Saji F. (2004) Concurrent chemoradiation therapy for high-risk cervical cancer (in Japanese). Sanfujinka Chiryou 88:17-23
48. Fuwa N, Kodaira T, Kamata M, et al. (2002) Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP). Am J Clin Oncol 25:565-569
49. Rose PG. (2002) Chemoradiotherapy for cervical cancer. Eur J Cancer 38:270-278
50. Sukumvanich P, Einstein MH, Huang GS, et al. (2004) Comparison of weekly versus three weekly concomitant cisplatin/RT in patients with cervical carcinoma. The 2004 Annual Meeting on Women's Cancer.
51. Fields AL, Anderson PS, Goldberg GL, et al. (1996) Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix. Gynecol Oncol 61:416-422
52. Muderspach LL, Curtin JP, Roman LD, et al. (1997) Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecol Oncol 65:336-342
53. Savarese A, Cognetti F (2003) New drugs in the treatment of recurrent or metastatic cervical cancer. Crit Rev Oncol Hematol 48:323-327
54. Rose PG, Blessing JA, Gershenson DM, et al. (1999) Pachtaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 17:2676-2680
55. Piver MS, Ghamande SA, Eltabbakh GH, et al. (1999) First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - a phase II study. Gynecol Oncol 75:334-337
56. Papadimitriou CA, Sarris K, Moulopoulos LA, et al. (1999) Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 17:761-766
57. Park DC, Kim JH, Lew YO, et al. (2004) Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol 92:59-63
58. Mickiewicz E, Garbino C, Hurtado de Mendoza F, et al. (2001) Paclitaxel and carboplatin as first line treatment for advanced carcinoma of the cervix. Proc Am Soc Clin Oncol 20: 825
59. Zanetta G, Fei F, Parma G, et al. (1999) Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer. Ann Oncol 10:1171-1174
60. D'Agostino G, Distefano M, Greggi S, et al. (2002) Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin. Cancer Chemother Pharmacol 49:256-260
61. Moore DH, McQuellon PP, Blessing JA, et al. (2001) A randomized phase III study of cisplatin versus cisplatin plus paclitaxel in stage iv, recurrent or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Proc Am Soc Clin Oncol 20:801
62. Kitagawa R, Katsumata N, Yamada Y, et al. (2004) Phase II trial of paclitaxel(T) and carboplatin in patients with recurrent or metastatic cervical carcinoma. Proc Am Soc Clin Oncol 23: 5048
63. Tiersten AD, Selleck MJ, Hershman DL, et al. (2004) Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma. Gynecol Oncol 92:635-638
64. Sarosy G, Kohn E, Link C, et al. (1992) Taxol dose intensification (DI) in patients with recurrent ovarian cancer. Proc Am Soc Clin Oncol 11:716
65. Garin A, Moiseyenko V, Roszak A, et al. (2001) Randomized phase II study of irinotecan or irinotecan in combination with cisplatin or cisplatin in first line in patients with metastatic squamous cell carcinoma of the cervix. Proc Am Soc Clin Oncol 20:826
66. Holmes FA, Kudelka AP, Kavanagh JJ, et al. (1995) Current status of clinical trials with paclitaxel and docetaxel. In: George GI, Chen TT, Ojima I, Vyas DM (eds) ACS symposium-in-print: taxane anticancer agents: basic science and current status, volume 583. ACS, Washington, DC, pp 31-57
67. Pazdur R, Kudelka AP, Kavanagh JJ, et al. (1993) The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere). Cancer Treat Rev 19:351-386
68. Mahfouf H, Bouzid K (2001) Gemcitabine (G) and cisplatin (C) in recurrent, advanced or metastatic cervical squamous cell carcinoma. Proc Am Soc Clin Oncol 20:824
69. http://www.nccn.org/professionals/physician-gls/PDF/cervical.pdf
70. Nag S, Erickson B, Thomadsen B, et al. (2000) The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 48:201-211